BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11337547)

  • 1. Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy.
    Brink I; Reinhardt MJ; Hoegerle S; Altehoefer C; Moser E; Nitzsche EU
    J Nucl Med; 2001 Apr; 42(4):591-5. PubMed ID: 11337547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy.
    Kawano T; Suzuki A; Ishida A; Takahashi N; Lee J; Tayama Y; Oka T; Yokota S; Inoue T
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):831-6. PubMed ID: 14963698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic thymic uptake of 18F-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment.
    Jerushalmi J; Frenkel A; Bar-Shalom R; Khoury J; Israel O
    J Nucl Med; 2009 Jun; 50(6):849-53. PubMed ID: 19443604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive gallium-67 and thallium-201 scans in thymic rebound after chemotherapy for lymphoma.
    Akaki S; Shinya T; Sato S; Kuroda M; Kanazawa S
    Ann Nucl Med; 2006 Feb; 20(2):161-3. PubMed ID: 16615427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic enlargement and FDG uptake in three patients: CT and FDG positron emission tomography correlated with pathology.
    Wittram C; Fischman AJ; Mark E; Ko J; Shepard JA
    AJR Am J Roentgenol; 2003 Feb; 180(2):519-22. PubMed ID: 12540464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT.
    Nakahara T; Fujii H; Ide M; Nishiumi N; Takahashi W; Yasuda S; Shohtsu A; Kubo A
    Br J Radiol; 2001 Sep; 74(885):821-4. PubMed ID: 11560830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
    Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
    J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic extension in the superior mediastinum in patients with thymic hyperplasia: potential cause of false-positive findings on 18F-FDG PET/CT.
    Smith CS; Schöder H; Yeung HW
    AJR Am J Roentgenol; 2007 Jun; 188(6):1716-21. PubMed ID: 17515398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive thymic hyperplasia following chemotherapy for children with lymphoma: computed tomography may be able to provide valuable information to avoid over-treatment.
    Tian L; Cai PQ; Cui CY; Mo YX; Gong X; Fan W
    Eur J Cardiothorac Surg; 2015 May; 47(5):883-9. PubMed ID: 25079775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.
    Goethals I; Hoste P; De Vriendt C; Smeets P; Verlooy J; Ham H
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):462-7. PubMed ID: 19820931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency and spectrum of thymus 2-[fluorine-18] fluoro-2-deoxy-D-glucose uptake patterns in hyperthyroidism patients.
    Chen YK; Yeh CL; Chen YL; Wang SC; Cheng RH; Kao PF
    Acad Radiol; 2011 Oct; 18(10):1292-7. PubMed ID: 21893295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C; Osman M; Pannu HK; Wahl RL
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated 18F-FDG uptake in skeletal muscles and thymus: a clue for the diagnosis of Graves' disease.
    Chen YK; Chen YL; Liao AC; Shen YY; Kao CH
    Nucl Med Commun; 2004 Feb; 25(2):115-21. PubMed ID: 15154698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic hyperplasia following chemotherapy in adults with lymphoma: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings and correlation with T cell repopulation.
    Sun DP; Ding CY; Wang L; Liang JH; Fan L; Wu YJ; Tian T; Li TN; Xu W; Li JY
    Leuk Lymphoma; 2015; 56(8):2344-9. PubMed ID: 25407653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET.
    Sasaki M; Kuwabara Y; Ichiya Y; Akashi Y; Yoshida T; Nakagawa M; Murayama S; Masuda K
    J Nucl Med; 1999 Oct; 40(10):1595-601. PubMed ID: 10520697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma.
    Franke FC; Damek A; Steglich J; Kurch L; Hasenclever D; Georgi TW; Wohlgemuth WA; Mauz-Körholz C; Körholz D; Kluge R; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlen J; Fernández-Teijeiro A; Cepelova M; Klekawka T; Attarbaschi A; Ceppi F; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Moellers M; Buerke B; Stoevesandt D
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30421. PubMed ID: 37243889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.